Y10S 424/812
Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific
Official title: Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
Y10S424/812 (Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific) appears on 136 US grants and 35 published applications in this corpus.
Search patents in Y10S- Granted patents
- 136
- Published applications
- 35
- Assignees
- 75
- Inventors
- 212
- Latest grant
- 12 Jul 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 7 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 16 | 0 |
| 1999 | 11 | 0 |
| 2000 | 16 | 0 |
| 2001 | 11 | 3 |
| 2002 | 4 | 4 |
| 2003 | 3 | 3 |
| 2004 | 4 | 6 |
| 2005 | 1 | 5 |
| 2006 | 3 | 2 |
| 2007 | 2 | 1 |
| 2008 | 2 | 3 |
| 2009 | 1 | 3 |
| 2010 | 2 | 0 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Internalizing ErbB2 antibodies12 Jul 2016US 9,388,244 B2The Regents of the University of California
- Vaccines with enhanced immune response and methods for their preparation25 Aug 2015US 9,114,174 B2Immunovaccine Technologies Inc.
- Internalizing erbB2 antibodies10 Mar 2015US 8,974,792 B2The Regents of the University of California
- Vaccines with enhanced immune response and methods for their preparation14 Jan 2014US 8,628,937 B2Immunovaccine Technologies Inc.
- Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseases10 Dec 2013US 8,603,487 B2AC Immune SA
- Internalizing ErbB2 Antibodies29 Sep 2016US 2016/0279262 A1The Regents of the University of California
- Internalizing ErbB2 Antibodies27 Aug 2015US 2015/0239976 A1The Regents of the University of California
- Vaccines with enhanced immune response and methods for their preparation10 Apr 2014US 2014/0099358 A1Immunovaccine Technologies Inc.
- Internalizing ErBB2 Antibodies19 Dec 2013US 2013/0337039 A1The Regents of the University of California
- Internalizing ErbB2 antibodies8 Sep 2011US 2011/0218333 A1The Regents of the University of California
Most cited
By later US patents
- Method of encapsulating biologically active materials in lipid vesicles1,201US 4,235,871 A1980
- Liposomes containing modified cholesterol for organ targeting853US 4,544,545 ATrustees of the University of Massachusetts · 1985
- Targeted gas and gaseous precursor-filled liposomes316US 6,071,495 AImaRx Pharmaceutical Corp. · 2000
- Method of preparing gas and gaseous precursor-filled microspheres302US 5,585,112 AImaRx Pharmaceutical Corp. · 1996
- Paucilamellar lipid vesicles266US 4,911,928 AMicro-Pak, Inc. · 1990